NEW YORK ( TheStreet) -- ViroPharma (Nasdaq: VPHM) hit a new 52-week high Monday as it is currently trading at $31.45, above its previous 52-week high of $31 with 159,260 shares traded as of 9:45 a.m. ET. Average volume has been 1.2 million shares over the past 30 days. ViroPharma has a market cap of $2.08 billion and is part of the health care sector and drugs industry. Shares are up 11.8% year to date as of the close of trading on Friday. ViroPharma Incorporated, together with its subsidiaries, engages in the development and commercialization of therapeutic products that address serious diseases in the United States and internationally. The company has a P/E ratio of 20.9, above the average drugs industry P/E ratio of 20.2 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter